GENX का आंतरिक मूल्यांकन और मौलिक विश्लेषण - Genex Pharmaceutical Inc

वॉचलिस्ट प्रबंधक

वॉचलिस्ट

कीमत: 0.0001 USD

बाज़ार पूंजीकरण: $1.8 हज़ार

G	Genex Pharmaceutical Inc OTC:GENX	CN

आंतरिक मूल्य

GENX latest financial reports are more than 15 years old.

GENX doesn't have a meaningful market cap.

Genex Pharmaceutical Inc का आंतरिक मूल्य भरोसेमंद ढंग से निकालने के लिए पर्याप्त डेटा नहीं है।

क्या हमारे मूल्यांकन वास्तव में कारगर हैं? बैकटेस्ट के परिणाम देखें .

मौलिक विश्लेषण

Genex Pharmaceutical क्या करती है

स्वास्थ्य सेवा Health Care

Genex Pharmaceutical, Inc. engages in the development and production of Reconstituted Bone Xenograft, which is a medical device that accelerates bone healing. The company is headquartered in Tianjin, Tianjin and currently employs 86 full-time employees. The company went IPO on 2006-05-23. The Company’s main business is engaged in producing and distributing Reconstituted Bone Xenograft (RBX). The RBX is a medical device that accelerates bone healing. The firm distributes its medical devices to hospitals as well as other medical device customers that are not hospitals.

मुख्यालय: चीन CN
कर्मचारी: 86
IPO की तारीख: मई 23, 2006